132 related articles for article (PubMed ID: 24748183)
1. Cholangiocarcinoma and high-grade dysplasia in young patients with primary sclerosing cholangitis.
Liu R; Cox K; Guthery SL; Book L; Witt B; Chadwick B; Adler DG
Dig Dis Sci; 2014 Sep; 59(9):2320-4. PubMed ID: 24748183
[TBL] [Abstract][Full Text] [Related]
2. NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Boyd S; Mustamäki T; Sjöblom N; Nordin A; Tenca A; Jokelainen K; Rantapero T; Liuksiala T; Lahtinen L; Kuopio T; Kytölä S; Mäkisalo H; Färkkilä M; Arola J
Hepatol Commun; 2024 Apr; 8(4):. PubMed ID: 38551383
[TBL] [Abstract][Full Text] [Related]
3. Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis.
Eaton JE; Barr Fritcher EG; Gores GJ; Atkinson EJ; Tabibian JH; Topazian MD; Gossard AA; Halling KC; Kipp BR; Lazaridis KN
Am J Gastroenterol; 2015 Feb; 110(2):299-309. PubMed ID: 25623660
[TBL] [Abstract][Full Text] [Related]
4. Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity.
Kamp EJCA; Peppelenbosch MP; Doukas M; Verheij J; Ponsioen CY; van Marion R; Bruno MJ; Groot Koerkamp B; Dinjens WNM; de Vries AC
Clin Transl Gastroenterol; 2021 Oct; 12(10):e00410. PubMed ID: 34608877
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinoma.
Lapitz A; Azkargorta M; Milkiewicz P; Olaizola P; Zhuravleva E; Grimsrud MM; Schramm C; Arbelaiz A; O'Rourke CJ; La Casta A; Milkiewicz M; Pastor T; Vesterhus M; Jimenez-Agüero R; Dill MT; Lamarca A; Valle JW; Macias RIR; Izquierdo-Sanchez L; Pérez Castaño Y; Caballero-Camino FJ; Riaño I; Krawczyk M; Ibarra C; Bustamante J; Nova-Camacho LM; Falcon-Perez JM; Elortza F; Perugorria MJ; Andersen JB; Bujanda L; Karlsen TH; Folseraas T; Rodrigues PM; Banales JM
J Hepatol; 2023 Jul; 79(1):93-108. PubMed ID: 36868481
[TBL] [Abstract][Full Text] [Related]
6. Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data.
Hu C; Iyer RK; Juran BD; McCauley BM; Atkinson EJ; Eaton JE; Ali AH; Lazaridis KN
BMC Gastroenterol; 2023 Apr; 23(1):129. PubMed ID: 37076803
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
[TBL] [Abstract][Full Text] [Related]
8. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis.
Tabibian JH; Enders F; Imam MH; Kolar G; Lindor KD; Talwalkar JA
Ann Hepatol; 2014; 13(3):384-9. PubMed ID: 24756015
[TBL] [Abstract][Full Text] [Related]
9. Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk.
Nanjundappa RH; Christen U; Umeshappa CS
Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37555943
[TBL] [Abstract][Full Text] [Related]
10. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.
Schramm C; Sapuk A; Hoyer D; Radünz S; Schmidt H
Z Gastroenterol; 2024 Jan; 62(1):37-42. PubMed ID: 38195106
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Management of Primary Sclerosing Cholangitis.
Assis DN; Bowlus CL
Clin Gastroenterol Hepatol; 2023 Jul; 21(8):2065-2075. PubMed ID: 37084929
[TBL] [Abstract][Full Text] [Related]
12. Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.
Ilyas SI; Eaton JE; Gores GJ
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2152-65. PubMed ID: 26051390
[TBL] [Abstract][Full Text] [Related]
13. Cancer surveillance in patients with primary sclerosing cholangitis.
Razumilava N; Gores GJ; Lindor KD
Hepatology; 2011 Nov; 54(5):1842-52. PubMed ID: 21793028
[TBL] [Abstract][Full Text] [Related]
14. Management of perihilar cholangiocarcinoma in the era of multimodal therapy.
Valero V; Cosgrove D; Herman JM; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):481-95. PubMed ID: 22928900
[TBL] [Abstract][Full Text] [Related]
15. Outcome after resection for perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis: an international multicentre study.
Jansson H; Olthof PB; Bergquist A; Ligthart MAP; Nadalin S; Troisi RI; Groot Koerkamp B; Alikhanov R; Lang H; Guglielmi A; Cescon M; Jarnagin WR; Aldrighetti L; van Gulik TM; Sparrelid E;
HPB (Oxford); 2021 Nov; 23(11):1751-1758. PubMed ID: 33975797
[TBL] [Abstract][Full Text] [Related]
16. [Primary sclerosing cholangitis-Diagnosis and treatment 2024].
Trauner M; Halilbasic E; Tatscher E; Fickert P
Inn Med (Heidelb); 2024 Apr; 65(4):347-356. PubMed ID: 38498179
[TBL] [Abstract][Full Text] [Related]
17. Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitis.
Tan N; Ngu N; Worland T; Lee T; Abrahams T; Freeman E; Hannah N; Gazelakis K; Madden RG; Lynch KD; Valaydon Z; Sood S; Dev A; Bell S; Thompson AJ; Ding JN; Nicoll AJ; Liu K; Pandya K; Gow P; Lubel J; Kemp W; Roberts SK; Majeed A
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38696372
[TBL] [Abstract][Full Text] [Related]
18. Erratum: NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study.
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38727679
[No Abstract] [Full Text] [Related]
19. Primary sclerosing cholangitis hospitalizations in the United States: characteristics and predictors of clinical outcomes.
Elfert K; Abosheaishaa H; Aboursheid T; Beran A; Ahmed M; Musallam R; Al-Taee A
Proc (Bayl Univ Med Cent); 2023; 36(6):700-704. PubMed ID: 37829220
[TBL] [Abstract][Full Text] [Related]
20. The Role of Immunoglobulin G4 in Outcomes of Primary Sclerosing Cholangitis.
Vujasinovic M; Said K; Villard C; Carlsson J; Poli C; Maisonneuve P; Löhr JM
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
